Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1908631 | 0.89 | LTA4H (0.50) | LMNAALDH1A1SMN1; SMN2ESR1NR5A1 | |
| SCHEMBL17445912 | 0.86 | ALDH1A1 (0.66) | LMNAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL13652493 | 0.85 | LMNA (0.55) | LMNAALDH1A1MAPTSMN1; SMN2ESR1 | |
| SCHEMBL17445914 | 0.84 | HRH3 (0.64) | LMNAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL18686307 | 0.82 | ESR1 (0.48) | LMNAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL15706822 | 0.82 | ESR1 (0.61) | LMNAALDH1A1SMN1; SMN2ESR1 | |
| SCHEMBL10800469 | 0.81 | KCNA3 (0.54) | — | |
| SCHEMBL17703302 | 0.81 | ITGB3 (0.45) | SMN1; SMN2HRH3ESR1 | |
| SCHEMBL14163821 | 0.81 | LMNA (0.51) | LMNAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL9972846 | 0.81 | ESR1 (0.47) | LMNAALDH1A1SMN1; SMN2HRH3ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10007183-B2 | Compound for forming organic film, and organic film composition using the same, process for forming organic film, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-06-26 | — | — | US | disclosed |
| US-9977330-B2 | Compound for forming organic film, and organic film composition using the same, process for forming organic film, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10007183-B2 | Compound for forming organic film, and organic film composition using the same, process for forming organic film, and patterning process | OR10J3, RER1, OLA1 | LMNA 2005/4885ALDH1A1 1407/4885MAPT 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.